Navigation Links


Plac in Medical News

diaDexus Receives CE Mark Certification for the PLAC(R) Test

...also announced the first shipment of the CE Marked plac Test to Europe. The plac Test is the only blood test cleared by the FDA to ...chemic stroke associated with atherosclerosis. The plac Test measures lipoprotein-associated phospholipase...

More>>

Plac in Medical Technology

Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2 Predicts Heart Disease Risk in Metabolic Syndrome Patients

... the University of Utah in Salt Lake City used the plac test from diaDexus to measure Lp-PLA2 levels in bl... diagnostic products with high clinical value. The plac test is a simple blood test that has been cleared ...ssociated with atherosclerosis. In addition to the plac test, diaDexus is developing a pipeline of novel c...

More>>

Plac in Medical Dictionary

ENT

...cumented. Estrogen replacement therapy reduces a woman's risk of: ... plac ENT A PREVIA Hospitalization or highly restricted at-home bed rest is usually recommended if plac ent a previa is diagnose d after the twentieth week of pregnancy . E...

More>>

Plac in Biological Technology

diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players

...risk for suffering a heart attack or stroke. The plac Test is the only blood test cleared by the FDA to ...chemic stroke associated with atherosclerosis. The plac Test measures lipoprotein-associated phospholipase...rmer NFL Quarterback. "We are pleased to offer the plac Test which provides new information, beyond tradit...

Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines

...cused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiology and oncology. The plac Test for Lp-PLA2 is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and ischemic stroke associated wit...

diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test

...e exclusive customer channel for its new automated plac Test for the Hitachi, Hitachi Roche P-Modular and ... these popular clinical chemistry analyzers. The plac Test is the only blood test cleared by the FDA to ...eatment can prevent heart attacks and strokes. The plac Test measures lipoprotein-associated phospholipase...

More>>

Other TagsTicsTicsTicsTicsTicsTicsTicsTicshazardWBCMMRNBENBE
Breaking Biology News(10 mins):Newly discovered mechanism allows cells to change state 2More than fish bait: Worms unlock secrets to new epilepsy treatments 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4PDL BioPharma to Present at Oppenheimer 26amp 3B Co 20th Annual Healthcare Conference on November 4 2009 14619 1Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 1Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 2Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 3Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 4Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 5Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 6Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 7Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 8Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 1Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 2Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 3Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 4Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 5Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 6Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 7Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 8Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 9Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 10Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 11Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 12Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 13Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 14Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 15Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 16Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 17Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 18Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 19Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 20Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 21Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 22
Other Contentsapoptosisapoptosisapoptosisapoptosisapoptosisapoptosisapoptosisarchaeaarchaeaarchaeaartificialartificialartificialartificialartificialartificialartificialartificialtechniquetechniquetechniquetechniquetechniquetechniquetechniquetechniquetechniqueasepticasepticasepticsynthasesynthasesynthasesynthasesynthase